Ranger Biotechnologies A/S — Credit Rating and Financial Key Figures
CVR number: 32280404
C.F. Tietgens Boulevard 30 A, Fraugde 5220 Odense SØ
info@rangerbiotechnologies.com
tel: 53623170
rangerbiotechnologies.com
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 2 429.00 | 5 709.00 | 7 095.00 | 1 711.00 | - 223.70 |
| Employee benefit expenses | -2 421.00 | -5 386.00 | -6 069.00 | -5.00 | - 128.30 |
| Total depreciation | -2.00 | - 195.00 | - 639.00 | - 277.00 | - 791.78 |
| EBIT | 6.00 | 128.00 | 387.00 | 1 429.00 | -1 143.78 |
| Other financial income | 2.00 | 3.00 | 3.00 | 5.00 | 6.64 |
| Other financial expenses | -8.00 | -20.00 | -18.00 | -2.00 | -0.96 |
| Pre-tax profit | 111.00 | 372.00 | 1 432.00 | -1 138.09 | |
| Income taxes | 61.00 | ||||
| Net earnings | 172.00 | 372.00 | 1 432.00 | -1 138.09 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Development expenditure | 193.09 | ||||
| Intangible assets total | 193.09 | ||||
| Buildings | 150.00 | 1 230.00 | 952.00 | 160.00 | |
| Machinery and equipment | 36.00 | 1 760.00 | |||
| Tangible assets total | 36.00 | 1 910.00 | 1 230.00 | 952.00 | 160.00 |
| Investments total | 200.00 | 204.00 | 210.34 | ||
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 57.00 | 226.00 | |||
| Current amounts owed by group member comp. | 61.00 | 64.00 | 67.00 | 91.00 | 96.59 |
| Prepayments and accrued income | 1.00 | 40.00 | 57.00 | 45.00 | 57.01 |
| Current other receivables | 127.00 | 1 038.00 | 550.00 | 5.00 | 132.27 |
| Current deferred tax assets | 61.00 | ||||
| Short term receivables total | 189.00 | 1 203.00 | 674.00 | 198.00 | 511.87 |
| Cash and bank deposits | 2 017.00 | 2 555.00 | 580.00 | 1 424.00 | 523.77 |
| Cash and cash equivalents | 2 017.00 | 2 555.00 | 580.00 | 1 424.00 | 523.77 |
| Balance sheet total (assets) | 2 242.00 | 5 668.00 | 2 684.00 | 2 778.00 | 1 599.08 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 9 415.00 | 9 415.00 | 9 415.00 | 9 415.00 | 9 414.79 |
| Other reserves | 193.09 | ||||
| Retained earnings | -8 697.00 | -8 697.00 | -8 525.00 | -8 154.00 | -6 915.10 |
| Profit of the financial year | 172.00 | 372.00 | 1 432.00 | -1 138.09 | |
| Shareholders equity total | 718.00 | 890.00 | 1 262.00 | 2 693.00 | 1 554.69 |
| Non-current other liabilities | 13.00 | ||||
| Non-current liabilities total | 13.00 | ||||
| Current loans from credit institutions | 60.00 | 17.00 | 15.69 | ||
| Current trade creditors | 1 361.00 | ||||
| Other non-interest bearing current liabilities | 530.00 | 473.00 | 61.00 | 27.00 | 28.70 |
| Accruals and deferred income | 934.00 | 4 288.00 | 45.00 | ||
| Current liabilities total | 1 524.00 | 4 778.00 | 1 422.00 | 72.00 | 44.39 |
| Balance sheet total (liabilities) | 2 242.00 | 5 668.00 | 2 684.00 | 2 778.00 | 1 599.08 |
CreditReports API
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.